Citations

Clear

2117 citation(s) found for "Mayo, Steven".

Enterprise-wide implementation of multicancer detection testing across a large academic health system.
Gilman, Elizabeth A. , Giridhar, Karthik, Chaudhuri, A, Blechman, Samuel, Croghan, Ivana T. , Ressler, Steven, Ghosh, Aditya , Ressler, Steven W. , Hurt, Ryan T.

Mayo Clinic

Journal of Clinical Oncology | May 27, 2026 | Volume: 44 | Issue: 16_suppl | Pages: 10578-10578

10.1200/jco.2026.44.16_suppl.10578 Get It

10578 Background: Multicancer detection (MCD) testing using cell-free DNA methylation patterns is a novel blood-based approach to cancer screening. In 2022, Mayo Clinic implemented offering MCD testing into routine clinical practice. Prior real-world reports have been limited to single-site experiences. We evaluated enterprise-wide implementation of MCD testing across all three Mayo Clinic sites using the Mayo Clinic Platform. Methods: We performed a retrospective analysis of de-identified clinical data from Mayo Clinic Platform Discover, including GRAIL Galleri tests performed at Mayo Clinic sites in Rochester, MN; Scottsdale, AZ; and Jacksonville, FL. This activity did not require IRB review per 45 CFR 46.102. Demographics, test results, cancer diagnoses, and prior cancer history were extracted using a privacy-preserving protocol, with data de-identified by expert determination. ICD-10 diagnostic codes were used to identify subsequent cancer diagnoses. Results: A total of 8,201 Galleri tests were performed in 7,300 patients; some patients underwent repeat testing. Fifty-seven tests (0.7%) were positive. Among MCD-positive patients, cancer diagnostic codes were identified in 32 patients, yielding a positive predictive value (PPV) of 58.7%. The most common cancers identified were oropharyngeal (34.4%), lymphoid and hematopoietic (34.4%), and gastrointestinal malignancies (18.8%).Among 8,144 MCD-negative tests (99.3% of all testing performed), 423 patients (5.2%) subsequently received a cancer diagnostic code, yielding a negative predictive value of 92.5%. The most commonly identified cancers in this group were male genital organs (36.6%), urinary tract (10.6%), and thyroid or other endocrine glands (7.3%). Overall, 10.1% of patients had a prior cancer history, which was more common in MCD-positive than MCD-negative patients (22.6% vs 10.0%). Patients with positive tests were older (mean age 68.4 vs 61.5 years) and more often male (67% vs 62%). Race distribution was similar. Conclusions: Enterprise-wide implementation of MCD testing across diverse clinical settings is feasible within routine workflows. Over half of positive tests were associated with cancer diagnostic codes, supporting the clinical promise of MCD testing. Limitations include incomplete capture of externally diagnosed cancers and lack of cancer signal-of-origin data. The Mayo Clinic Platform enables scalable, secure analytics to support future cancer interception strategies.
Factors associated with variation in treatment of the distal radioulnar joint after plate fixation of distal radial fractures
Drost, Alexander , Brinkman, Niels, Ring, David , Moran, Steven L, Arora, Rohit, Schep, N W L , Ring, David , (24182938), Alexander Drost, Brinkman, Niels, Moran, Steven L. , Arora, Rohit

Mayo Clinic

Journal of Hand Surgery (European Volume) | May 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/17531934261449057 | PMID 42200213 Get It

Introduction: Evidence suggests that the distal radioulnar joint injury associated with an operatively treated displaced fracture of the distal radius does not benefit from specific treatment after the radius is realigned. To better understand variation in treatment of the distal radioulnar joint we performed a scenario-based experiment presenting radiographs of displaced distal radial fractures accompanied by clinical scenarios with randomized aspects. Methods: In a survey-based experiment, participants of the Science of Variation Group viewed a random subset of five of 10 sets of radiographs showing displaced fractures of the distal radius before and after anterior plate fixation. Each was accompanied by a clinical scenario with trauma energy level, age and gender randomized. Participants indicated their preferred distal radioulnar joint treatment: none, cast immobilization, operative reattachment of ligaments or ulnar styloid fixation, or distal radioulnar joint pinning. Factors associated with any treatment and with reattachment were sought in multivariable regression. Results: Surgeons recommended distal radioulnar joint treatment in 67% (404 of 607) of the scenarios, most commonly cast immobilization in 41% (247 of 607). Recommendation for any distal radioulnar joint treatment was associated with younger patient age, and for reattachment specifically, was associated with younger patient age, high-energy trauma and fracture of the base of the ulnar styloid. Conclusions: The observation of frequent recommendation for distal radioulnar joint treatment, relatively more so for younger patients with higher energy injuries, and some tendency to repair an aligned ulnar styloid base fracture may diverge from existing evidence.
A prospective risk analysis for the clinical commissioning of a dose-driven continuous scanning proton therapy system
Herchko, Steven, Liang, Xiaoying, Beltran, Chris, Liang, Xiaoying, Shen, Jiajian , Furutani, Keith M.

Mayo Clinic

Frontiers in Oncology | May 20, 2026 | Volume: 16 | Issue: No issue available | Pages: No page available

10.3389/fonc.2026.1826522 | PMID 42245713 Get It

Introduction Proton dose driven continuous scanning (DDCS) is a form of proton pencil beam scanning (PBS) in which the beam may remain on during transitions between successive spots. Mayo Clinic Florida (MCF) is preparing to commission a synchrotron-based proton therapy system designed for DDCS, incorporating novel irradiation control features. Given the novelty and complexity of this system, a systematic risk-based analysis was performed to inform upcoming commissioning strategies. Methods A prospective risk analysis was conducted using the American Association of Physicists in Medicine (AAPM) Task Group 100 (TG 100) framework. A comprehensive process map of the DDCS irradiation control workflow was developed. Failure modes and effects analysis (FMEA) was performed to identify potential delivery system failure modes and to score each failure mode based on occurrence, severity, and lack of detectability. Targeted mitigation and commissioning strategies were then developed to address the highest-risk items. Results Twenty-nine delivery system failure modes were identified. The highest-risk failure modes were specific to DDCS operation. Targeted commissioning strategies were defined, including scan path measurement and modeling, validation of move and flap dose, dose monitor collection efficiency testing, spot position monitor performance evaluation, and verification of control system intervention behavior. Incorporation of these strategies into the commissioning plan reduced the mean RPN by more than 50%. Discussion This work provides a detailed description of the MCF proton DDCS irradiation control system and uses a TG 100 based approach for identifying system-specific risks. As new systems incorporate technologies for which limited guidance exists, institutions must perform their own risk analyses to determine appropriate quality management strategies.
B80-5-06 Reversible Hypoxemia Due to Intra-Sarcoma Shunt: A Case Study
Packard, D, Stultz, B R, Robinson, S I, Yadav, S, Stultz, Benjamin R. , Robinson, Steven I.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | May 18, 2026 | Volume: 212 | Issue: Supplement_1 | Pages: No page available

10.1093/ajrccm/aamag162.3823 Get It

Abstract Introduction Solid tumors modify local angiogenesis and co-opt surrounding vasculature to maintain energy supply required for ongoing growth. This process is often complicated by metastasis and hemorrhage. Pulmonary tumors can rarely create intrapulmonary shunt physiology and hypoxemia in this manner; this has been described most often in bronchoalveolar carcinoma. We present a case of malignant intrapulmonary shunt occurring with spindle cell sarcoma, which resolved with arterial embolization. Case Presentation A 72-year-old male with a history of stage IV spindle cell sarcoma with abdominal, vertebral, and pulmonary metastases presented to an outpatient appointment with three weeks of fatigue and decreased exercise tolerance. He had no history of parenchymal lung disease nor any home oxygen requirement. In clinic, he was found to require 6L per minute of supplemental oxygen to maintain saturation of 88%. He was directly admitted to the oncology service. Initial laboratory evaluation was unremarkable. CT imaging demonstrated normal lung parenchyma, no pulmonary embolism, and an 11cm vascular tumor involving proximal branches of the local pulmonary artery (Figure). Transthoracic echocardiography (TTE) with agitated saline revealed a large intrapulmonary shunt. As the patient had limited response to oxygen therapy, this intra-tumoral shunt was deemed the most likely cause of his hypoxemia. Surgical resection was considered but was deemed to confer limited clinical benefit in the setting of multiple metastases. Embolization of the local pulmonary artery was therefore pursued with Interventional Radiology. The patient tolerated the procedure well with complete resolution of hypoxemia post-procedure. His energy and mobility improved, and he was discharged home. Three months later, he continued to require no supplemental oxygen. Discussion While shunt physiology is commonly part of the differential for hypoxemia, it is rarely described as an oncologic complication. This appears to be the first report of such pathology in a sarcoma patient, and the first to report shunt resolution through arterial embolization rather than surgical resection or systemic anti-tumor therapy. In addition, previous cases typically describe shunt detection via selective pulmonary arterial occlusion by Swan-Ganz catheter, whereas here the noninvasive TTE with agitated saline was sufficient. While the few existing reports highlight good response to lobectomy or pneumonectomy, this case highlights the potential for minimally invasive vascular intervention. Despite the metastatic nature of this patient’s disease, he received significant, rapid physiologic and functional benefit from a procedure with less morbidity. Maintaining suspicion of intra-tumoral shunt physiology is appropriate for patients with vascular pulmonary masses and hypoxemia. This abstract is funded by: None
Analysis of Functional Outcomes and Donor Site Morbidity Following Fibula Flap Harvest in the Skeletally Immature Patient Population
Tunaboylu, Mehmet F., Zheng, Eugene, Odorico, Scott, Bakri, Karim , Moran, Steven L., Tunaboylu, Mehmet Furkan , Kuruoglu, Doga , Odorico, Scott K. , Houdek, Matthew T. , Moran, Steven L.

Mayo Clinic

Plastic & Reconstructive Surgery | May 11, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/prs.0000000000013172 | PMID 42112807 Get It

BACKGROUND: Free fibula flaps have been widely used for bony reconstruction in pediatric patients. While donor site complications have been well studied in adults, data in the pediatric population remains limited. This study exclusively reports donor-site morbidity following fibula flap harvests in the pediatric and adolescent population. METHODS: We reviewed all patients younger than 18 years with open physes who underwent fibula flap harvests at a single academic institution from 1997 to 2024. Demographics, clinical and surgical characteristics, and donor-site complications were recorded. RESULTS: Fifty-seven free fibula flaps were harvested from 55 pediatric patients (mean age 12 years; 29 female) with a mean follow-up of 6 years. Flaps were most commonly used for lower extremity reconstruction (52%) and following tumor resection (74%). Osteoarticular flaps (n=8) were associated with transient deep peroneal nerve palsy in four cases, all of which recovered antigravity dorsiflexion by 6 months. In standard segmental harvests (n=49), donor-site complications occurred in 38%, most frequently valgus ankle deformity (9%) and neuropathic pain (6%). Valgus deformity was more likely in patients with shorter distal residual fibula and an age–residual fibula index (A-RFI) <16. CONCLUSIONS: Vascularized fibula flaps are safe and versatile for pediatric skeletal reconstruction. Donor-site complications are common but generally manageable, with full recovery of nerve function. Osteoarticular harvests carry the highest risk of peroneal nerve injury, and valgus ankle deformity may occur, particularly with an age–residual fibula index <16. Careful planning and age-adjusted fibular preservation are essential to optimize outcomes.
Coronary Microvascular Dysfunction and Lipid Molecules: Pathophysiological Mechanisms, Clinical Assessment, and Therapeutic Implications
Hafez, Abdelrahman , Farina, Juan M. , Awad, Kamal, Pietri, Milagros Pereyra, Scalia, Isabel G. , Sheashaa, Hesham, Abdelfattah, Fatmaelzahraa , Razaghi, Mahshad , Ahmed, Sherif, Ibrahim, Ramzi, Simper, David, Lester, Steven J., Tamarappoo, Balaji, Ayoub, C A, Arsanjani, R A, Arsanjani, Reza , Pereyra, Milagros , Pereyra, Milagros , Sheashaa, Hesham , Abdelfattah, Fatmaelzahraa , Arsanjani, Reza , Farina, Juan M , Scalia, Isabel G , Awad, Kamal , Ahmed, Sherif , Ibrahim, Ramzi

Mayo Clinic

Journal of Personalized Medicine | May 6, 2026 | Volume: 16 | Issue: 5 | Pages: 254

10.3390/jpm16050254 | PMID 42188348 Get It

Coronary microvascular dysfunction (CMD) has emerged as a crucial contributor to cardiovascular morbidity and mortality, particularly in patients with ischemia and non-obstructive coronary arteries (INOCA). The condition arises from a complex interplay of structural and functional abnormalities within the small coronary vessels, driven by underlying molecular mechanisms including endothelial nitric oxide synthase (eNOS) uncoupling, oxidative stress, and chronic inflammation. Lipid metabolism plays a central role in this pathology, especially in the setting of elevated low-density lipoprotein cholesterol (LDL-C). Furthermore, the protective capacity of high-density lipoprotein (HDL) is increasingly understood to depend on its functionality rather than absolute levels, as it can become dysfunctional and pro-inflammatory in pathological states. Emerging evidence has identified lipoprotein(a) [Lp(a)] and triglyceride-rich lipoproteins as significant, independent contributors to microvascular injury. Comprehensive clinical assessment of microvascular dysfunction therefore requires integration of advanced lipid profiling, including apolipoprotein B (ApoB), [Lp(a)], and the triglyceride-glucose (TyG) index with invasive and non-invasive measures of coronary flow reserve to more precisely stratify risk. In this narrative review, we synthesize current observational, mechanistic, and early interventional data linking diverse lipid phenotypes to coronary microvascular dysfunction. We propose a concept of lipid-driven CMD endotypes, such as ApoB-/particle overload, dysfunctional HDL, Lp(a)-mediated risk, and metabolic/TyG-high states, and map these to a practical, mechanism-informed management framework. While intensive LDL-C lowering with high-intensity statins and combination therapy remains guideline-directed care for high-risk patients, evidence for dedicated microvascular benefit from newer lipid and cardiometabolic agents is still largely hypothesis-generating. A personalized approach that aligns lipid phenotyping, CMD endotyping, and existing guideline-based therapies may help refine risk assessment and inform future trials.
Refractory, Resistant and Recurrent Cytomegalovirus Infections in Solid Organ Transplant Recipients: Risk Factors and Clinical Outcomes
Bisono-Garcia, Bismarck Steven, Dinh, Christopher Anh-Thao, Ato, Benjo , Nair, Vaisak , Yetmar, Zachary A. , Razonable, Raymund R, Razonable, Raymund R. , Bisono, Bismarck , Bisono Garcia, Bismarck , Dinh, Christopher A , Nair, Vaisak O , Razonable, Raymund R , Yetmar, Zachary A

Mayo Clinic

Clinical Transplantation | April 29, 2026 | Volume: 40 | Issue: 5 | Pages: No page available

10.1111/ctr.70552 | PMID 42053990 Get It

ABSTRACT Background Cytomegalovirus (CMV) infection remains one of the most prevalent and consequential post solid organ transplant (SOT) infections. Treatment is often challenging, especially when dealing with refractory and resistant CMV infections. Methods We performed a retrospective multicenter cohort study of SOT recipients with clinically significant CMV infection (csCMVi) during 2010–2016. The primary outcome was early refractory CMV infection and secondary outcomes were drug resistance, CMV recurrence, and mortality. Analysis was done with Kaplan‐Meier, univariable logistic regression analysis, and multivariable Cox regression. Results We included 145 SOT recipients with csCMVi, majority were liver transplant (49%). Most common induction was an anti‐IL‐2 antibody (43.9%). The majority ( n = 82; 56.5%) were CMV D+/R‐ mismatch and presented asymptomatic infection (50.3%). After the initial 3 weeks of antiviral therapy, 13 (8.9%) patients had probable refractory csCMVi; most of them (10 [76.9%]) were CMV D+/R‐ mismatch. Longer time after transplant had lower risk (OR 0.68; CI 0.48–0.95, p = 0.029) while lower absolute lymphocyte count (ALC) had a higher risk of early refractory csCMVi (OR 1.54; CI 1.01–2.44, p = 0.048). Drug‐resistant csCMVi occurred in 7 patients (4.8%); a high initial CMV DNA level was associated with resistant csCMVi (OR 2.00; CI 1.08–3.93, p = 0.031). 25 patients (17.2%) experienced recurrent csCMVi within 6 months. 30 patients (20.7%) died; refractory, resistant or recurrent CMV infections were not associated with mortality. Conclusion Refractory csCMVi is associated with a low ALC and an earlier onset after transplant. Resistant csCMVi is associated with high initial CMV DNA levels. Recurrence of csCMVi is common and potentially associated with low ALC at the end of antiviral treatment.
Intra‐Articular Purified Exosome Product and Hyaluronan Attenuate Osteoarthritis Progression in a Minimally Invasive Turkey Model
Lei, Xing , Wang, Lei, Reisdorf, Ramona L., Brosig, Maggie A, Moran, Steven L, Evans, CH, Zhao, Chunfeng, Brosig, Maggie, Moran, Steven L., Evans, Christopher H., Zhao, Chunfeng

Mayo Clinic

Journal of Orthopaedic Research | April 29, 2026 | Volume: 44 | Issue: 5 | Pages: No page available

10.1002/jor.70207 | PMID 42051070 Get It

ABSTRACT Our study aimed to develop a novel, reproducible, minimally invasive turkey knee osteoarthritis (OA) model and evaluate whether intra‐articular hyaluronan (HA) alone or combined with purified exosome product (PEP) attenuates OA‐related functional and structural deterioration. OA was induced arthroscopically by transection of the anterior and posterior cruciate ligaments with resection of the anterior horn of the medial meniscus. Animals received intra‐articular injections of saline, HA, or PEP + HA at postoperative 2–5 weeks. Gait was assessed at 4, 8, and 12 weeks, and cartilage degeneration, subchondral bone sclerosis, osteophyte formation, synovial fibrosis, heterotopic ossification, and meniscal integrity were evaluated by quantitative CT and histology at week 12. Compared with saline, HA improved lameness, preserved cartilage glycosaminoglycan content, and reduced meniscal rupture, subchondral bone sclerosis, and periarticular heterotopic ossification. PEP + HA provided additional benefits, including prolonged stance phase, reduced synovial fibrosis, and greater chondroprotection than HA alone, while plantar pressure variables, subchondral bone remodeling, and patellar osteophytes did not differ between HA and PEP + HA. This turkey model reliably produces human‐like OA changes and enables longitudinal functional and structural assessment. Intra‐articular HA mitigated OA progression, and the addition of PEP conferred incremental joint protection.
The Incidence of Traumatic Carpal Fractures: A 10-Year Epidemiology Study
Tunaboylu, Mehmet Furkan , Selim, Omar A., Rodriques, Lucas Kreutz, Moran, Steven L., Selim, Omar , Kreutz‐Rodrigues, Lucas , Moran, Steven L.

Mayo Clinic

Journal of Wrist Surgery | April 24, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/a-2851-0386 Get It

Abstract Carpal fractures are uncommon, representing a small proportion of hand fractures. This study aimed to determine the incidence, injury mechanisms, treatment patterns, and complication rates of carpal fractures in Olmsted County, Minnesota, United States. A retrospective review was performed using the Rochester Epidemiology Project registry to identify carpal fractures between 2013 and 2023. Fractures were confirmed by radiographs, computed tomography, or radiology reports. Demographic data, injury mechanism, fracture laterality, and fracture characteristics were recorded. A total of 699 carpal fractures were identified. Most patients were men (57%) with a mean age of 43 years. The most common fracture was the scaphoid (44%), followed by the triquetrum (31%), hamate (9%), and trapezium (3%). The overall incidence was 53.6 per 100,000 person-years. Concomitant wrist fractures occurred in 22%, and multiple ipsilateral carpal fractures in 4.6%. Patients with triquetrum fractures had the highest mean age (54 years) and low surgical rates (2%), whereas hamate and trapezoid fractures occurred at younger ages (39 and 38 years) and had the highest surgical rates (28 and 33%, respectively). The most common injury mechanism was a fall onto an outstretched hand (n = 438). Overall, 14% (n = 98) of patients underwent surgery, of whom 77% were men. The highest nonunion rate was seen in hamate fractures (10.9%), followed by scaphoid waist and proximal pole fractures (10.5%). Nonscaphoid carpal fractures occur more frequently than previously reported and demonstrate variable age distribution, treatment rates, and nonunion risks. Understanding these patterns can improve diagnosis, guide treatment planning, and inform patient expectations. IV.